Coverage dated November 16, 2021 to November 17, 2021
U.S. looking to expand vaccine-making capacity
Headline from Arkansas Democrat-Gazette
The Biden administration is planning to invest billions of dollars to expand U.S. manufacturing capabilities on coronavirus vaccines to increase the supply of doses for poorer nations, the White House announced Wednesday.
Arkansas Democrat-Gazette's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
WASHINGTON (AP) — The Biden administration is making billions of dollars available to drugmakers to scale up domestic production of COVID-19 vaccines in the hopes of building capacity to produce
"The U.S. needs to make sure these companies, which they funded, are prioritizing public health rather than profits," said advocacy manager Robbie Silverman.
The Biden administration believes the boosted capacity of COVID-19 shots will help ease a global shortage of doses, particularly in lower- and middle-income nations.
The Biden administration is making billions of dollars available to drugmakers to scale up domestic production of COVID-19 vaccines to share with the world.
Pressed to address gaping inequality in global covid-19 vaccines, the Biden administration took steps Wednesday to make billions of dollars available to drugmakers to scale up domestic production to share with the world and prepare for the next pandemic.
WASHINGTON -- The United States is planning to invest billions of dollars in expanding COVID-19 manufacturing capacity to have at least a billion doses by the second half of next
The Biden administration is seeking to boost Covid-19 vaccine manufacturing to increase the global vaccine supply, particularly in developing nations, as the US continues its efforts to share more vaccines abroad.
The White House is aiming to spur the production of at least 1 billion doses a year. The funds will support companies that make mRNA vaccines, such as Pfizer and Moderna, by helping them expand their capacity by funding facilities, equipment, staff and training.
The Biden administration is planning to invest billions of dollars to expand U.S. manufacturing capabilities on coronavirus vaccines to increase the supply of doses for poorer nations, the White House announced Wednesday.
WASHINGTON — The Biden administration is making billions of dollars available to drugmakers to scale up domestic production of COVID-19 vaccines in the hopes of building capacity to produce an additional 1 billion shots per year to share with the...
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
U.S. looking to expand vaccine-making capacity | Since Then
